Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry-Reference-Cited by-同舟云学术

Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry

Published:2012-12-21 Issue:6 Volume:72 Page:1026-1031
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Gottenberg Jacques-Eric,Cinquetti Gael,Larroche Claire,Combe Bernard,Hachulla Eric,Meyer Olivier,Pertuiset Edouard,Kaplanski Guy,Chiche Laurent,Berthelot Jean-Marie,Gombert Bruno,Goupille Philippe,Marcelli Christian,Feuillet Séverine,Leone Jean,Sibilia Jean,Zarnitsky Charles,Carli Philippe,Rist Stephanie,Gaudin Philippe,Salliot Carine,Piperno Muriel,Deplas Adeline,Breban Maxime,Lequerre Thierry,Richette Pascal,Ghiringhelli Charles,Hamidou Mohamed,Ravaud Philippe,Mariette Xavier

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Cited by 201 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenesis of Sjögren syndrome;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Efficacy of disease-modifying antirheumatic drugs in primary Sjögren's syndrome-related interstitial lung disease;Medicina Clínica;2024-08

3. Update on the pathophysiology and treatment of primary Sjögren syndrome;Nature Reviews Rheumatology;2024-07-09

4. Executive summary: British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease;Rheumatology;2024-05-24

5. Emerging biologic frontiers for Sjogren’s syndrome: Unveiling novel approaches with emphasis on extra glandular pathology;Frontiers in Pharmacology;2024-05-17